Guillaume Charles
Leadership · Eclevar MedTech
Leading medical device teams work with Eclevar
Driving innovation in European clinical trials through AI-powered solutions and strategic partnerships with MedTech companies and investigator sites.
Study start-upSite feasibilityEU MDR & GCPEDC / MiloPatient recruitment
Head of Global Business Management
Site & MedTech Partnerships
Eclevar MedTech · Milo Health
Where Guillaume drives results.
Bridging investigator sites, MedTech sponsors and AI-enabled clinical technology to get European trials started faster.
Site partnerships and feasibility assessment across European investigator networks.
Next-generation EDC platform implementation with Milo Health.
Site qualification, contracting and regulatory compliance to first-patient-in.
EU MDR, GCP and the regulatory frameworks that govern EU device studies.
EDC optimization and site contracting to accelerate enrollment.
Strategic partnerships with sponsors and sites to accelerate patient access.
Partnerships that accelerate trials.
- ›Strategic MedTech partnerships , leading collaboration with sponsors and clinical sites across Europe.
- ›Milo AI-powered EDC , voice and image capture, risk prediction and EHR integration to streamline trials.
- ›Faster patient access , turning site relationships into quicker trial implementation.
Where the experience comes from.
Awards, funding, accountability
- ›5+ years in clinical operations across leading CROs (IQVIA, Fortrea)
- ›Clinical Project Management experience at Amgen
- ›Specialized in clinical trial design and EU regulations (MDR / GCP)
- ›Expert in site start-up, feasibility and regulatory processes
Europe’s best-rated medical device CRO.
Top tier at the xShare × EUCROF Open Call, awarded to Eclevar MedTech and its Milo Health platform, presented at EUCROF 2026 in Amsterdam.
Selected through the xShare Open Call for clinical research innovation, Horizon Europe.
Distinction confirmed by an independent third party, the CVBF, also an awardee of the xShare × EUCROF Open Call.
Start your European trial with the right sites.
Talk to Eclevar’s clinical operations and partnerships team about feasibility, site selection and study start-up.
A European team of former notified body reviewers
The people who build your evidence have sat on the other side of the table.
Dr Mark Da Costa
Dr Nikhil Khadabadi
Pierre-Marie BoutanquoiOur content, signed Eclevar.
Whitepapers and publications produced by our teams with our notified body partners.
A BSI and Eclevar whitepaper on the EU MDR.
Written with Notified Body BSI: a practical reading of the clinical evidence expectations under EU MDR 2017/745, the same evidence your file has to support.
Related pages
The services and topics connected to this page.
Tell us where your evidence stands today
Send us the device, the claim and the deadline. You get a written answer within 24 hours.
Your documents are reviewed confidentially. An NDA can be signed before we receive any technical or clinical information.